Nicholas Panay

2.5k total citations
40 papers, 1.4k citations indexed

About

Nicholas Panay is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nicholas Panay has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Genetics and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nicholas Panay's work include Menopause: Health Impacts and Treatments (21 papers), Estrogen and related hormone effects (14 papers) and Sexual function and dysfunction studies (6 papers). Nicholas Panay is often cited by papers focused on Menopause: Health Impacts and Treatments (21 papers), Estrogen and related hormone effects (14 papers) and Sexual function and dysfunction studies (6 papers). Nicholas Panay collaborates with scholars based in United Kingdom, United States and Italy. Nicholas Panay's co-authors include J. W. W. Studd, Susan R. Davis, Janice Rymer, John Studd, David F. Archer, James A. Simon, Myra S. Hunter, Rod Baber, Ιrene Lambrinoudaki and Margaret E. Wierman and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Human Reproduction.

In The Last Decade

Nicholas Panay

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Panay United Kingdom 20 823 496 449 445 238 40 1.4k
Geoffrey P. Redmond United States 18 808 1.0× 186 0.4× 360 0.8× 289 0.6× 490 2.1× 39 1.6k
Georgina E. Hale Australia 18 511 0.6× 332 0.7× 493 1.1× 432 1.0× 46 0.2× 23 1.3k
Duru Shah India 13 378 0.5× 182 0.4× 524 1.2× 423 1.0× 43 0.2× 41 1.2k
Lori Hollander United States 10 599 0.7× 236 0.5× 173 0.4× 322 0.7× 95 0.4× 16 1.0k
Uwe Mellinger Germany 22 531 0.6× 169 0.3× 691 1.5× 776 1.7× 158 0.7× 48 1.5k
Iris Granek United States 10 591 0.7× 475 1.0× 91 0.2× 142 0.3× 97 0.4× 11 956
S. Sherman United States 6 420 0.5× 222 0.4× 142 0.3× 201 0.5× 48 0.2× 9 906
Brinda Wiita United States 16 808 1.0× 590 1.2× 191 0.4× 113 0.3× 300 1.3× 27 1.5k
Susanne Tan Germany 27 503 0.6× 87 0.2× 1.6k 3.6× 905 2.0× 186 0.8× 62 2.4k
Wolfram E. Nolten United States 15 659 0.8× 586 1.2× 541 1.2× 193 0.4× 350 1.5× 34 1.7k

Countries citing papers authored by Nicholas Panay

Since Specialization
Citations

This map shows the geographic impact of Nicholas Panay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Panay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Panay more than expected).

Fields of papers citing papers by Nicholas Panay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Panay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Panay. The network helps show where Nicholas Panay may publish in the future.

Co-authorship network of co-authors of Nicholas Panay

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Panay. A scholar is included among the top collaborators of Nicholas Panay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Panay. Nicholas Panay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Panay, Nicholas, Richard A. Anderson, Marcelle I. Cedars, et al.. (2024). O-111 Premature ovarian insufficiency: new data and updated guidance. Human Reproduction. 39(Supplement_1). 1 indexed citations
2.
Wei, Li, et al.. (2022). Hormone replacement therapy prescribing in menopausal women in the UK: a descriptive study. BJGP Open. 6(4). BJGPO.2022.0126–BJGPO.2022.0126. 22 indexed citations
3.
Panay, Nicholas, et al.. (2021). Alternative and non-hormonal treatments to symptoms of menopause. Best Practice & Research Clinical Obstetrics & Gynaecology. 81. 45–60. 16 indexed citations
4.
Cai, Bin, James A. Simon, Paola Villa, et al.. (2020). No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA). Maturitas. 142. 38–44. 29 indexed citations
5.
Prague, Julia, Rachel Roberts, Alexander Comninos, et al.. (2019). Neurokinin 3 Receptor Antagonism Rapidly Improves Vasomotor Symptoms With Sustained Duration of Action. Obstetrical & Gynecological Survey. 74(4). 221–222. 1 indexed citations
6.
Davis, Susan R., Rod Baber, Nicholas Panay, et al.. (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. The Journal of Sexual Medicine. 16(9). 1331–1337. 26 indexed citations
7.
Prague, Julia, Rachel Roberts, Alexander Comninos, et al.. (2018). Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action. Menopause The Journal of The North American Menopause Society. 25(8). 862–869. 48 indexed citations
8.
Prague, Julia, Rachel Roberts, Alexander Comninos, et al.. (2017). Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. The Lancet. 389(10081). 1809–1820. 133 indexed citations
9.
Hamoda, Haitham, et al.. (2016). The British Menopause Society & Women’s Health Concern 2016 recommendations on hormone replacement therapy in menopausal women. Post Reproductive Health. 22(4). 165–183. 24 indexed citations
10.
Stevenson, John C., Nicholas Panay, & Claire Pexman-Fieth. (2013). Oral estradiol and dydrogesterone combination therapy in postmenopausal women: Review of efficacy and safety. Maturitas. 76(1). 10–21. 26 indexed citations
11.
Nagi, Jara Ben & Nicholas Panay. (2013). Premature ovarian insufficiency: how to improve reproductive outcome?. Climacteric. 17(3). 242–246. 35 indexed citations
12.
Bouchard, P, et al.. (2011). Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms. Climacteric. 15(1). 12–20. 32 indexed citations
13.
Panay, Nicholas. (2011). Taking an integrated approach: managing women with phytoestrogens. Climacteric. 14(sup2). 2–7. 5 indexed citations
14.
Birkhäuser, Martin, Nicholas Panay, David F. Archer, et al.. (2008). Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric. 11(2). 108–123. 63 indexed citations
15.
Panay, Nicholas, et al.. (2007). Cyclical dydrogesterone in secondary amenorrhea: Results of a double-blind, placebo-controlled, randomized study. Gynecological Endocrinology. 23(11). 611–618. 7 indexed citations
16.
Panay, Nicholas, et al.. (2007). Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric. 10(2). 120–131. 69 indexed citations
17.
Inskip, Hazel, et al.. (2004). A study to investigate the relationship between lifestyle factors and premenstrual symptoms. The Journal of the British Menopause Society. 10(2_suppl). 15–15. 5 indexed citations
18.
Panay, Nicholas, et al.. (2001). A Multicentre Double-Blind Crossover Study Comparing 100mg Transdermal Oestradiol with Placebo in the Treatment of Severe Premenstrual Syndrome. The Journal of the British Menopause Society. 7(3_suppl). 19–20. 2 indexed citations
19.
20.
Panay, Nicholas & A.M. Lower. (1999). New directions in the prevention of adhesion in laparoscopic surgery. Current Opinion in Obstetrics & Gynecology. 11(4). 379–385. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geoffrey P. Redmond Breakdown of academic impact, for papers by Georgina E. Hale Breakdown of academic impact, for papers by Duru Shah Breakdown of academic impact, for papers by Lori Hollander Breakdown of academic impact, for papers by Uwe Mellinger Breakdown of academic impact, for papers by Iris Granek Breakdown of academic impact, for papers by S. Sherman Breakdown of academic impact, for papers by Brinda Wiita Breakdown of academic impact, for papers by Susanne Tan Breakdown of academic impact, for papers by Wolfram E. Nolten
Rankless by CCL
2026